Skip to content
Open·Listed in the source's current feed today

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

Defense Health Agency Contracting Activity - DHACA

Go to the official application

Want a reminder before this closes?

We'll email you 3 days before the deadline. One email, then we stop.

Free. Verify your email, then we send one reminder only.

Posted
Aug 20, 2026
Closes
Nov 18, 2026 (in 32 days)

See more open grant funding like this

Get alerted when new grant funding matching "breast cancer breakthrough" opens, nationwide.

Checking your account…

Free includes 1 alert. New listings reach free search, alerts and AI search after 10 days. Unsubscribe anytime.

Classification and identifiers

Solicitation number
HT942526BCRPBTA122
Assistance listing (CFDA)
12.420

Amount

Amount not listed here. Check the official program.

Who can apply

Open to all

About this opportunity

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make breakthroughs in breast cancer. All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception. Applications must address the challenge in a way that can lead to a breakthrough and have major impact. The FY26 Breakthrough Award mechanism contains four different funding levels designed to support major (but not all) stages of research that will lead to clinical application. Each level specifies a distinct research scope. This program announcement discusses the Breakthrough Award Levels 1 and 2. Distinctive Features: * This funding mechanism allows for appl...

Refine this search